Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Frank Brosens’ Taconic Capital Bought More CA Inc. ($CA)

Frank Brosens’ Taconic Capital filed recently that the firm increased its activist stake in CA Inc. (CA) to 5.14%. According to the SEC filing, Taconic Capital now has 25.35 million shares of CA in its portfolio, up from 24.70 million shares at the end of the third quarter. The disclosure pushed CA to rise 4% on Thursday.

Frank Brosens

Taconic Capital also revealed that it believes the company’s board and management should take actions to boost the shareholder value, including returning more cash to shareholders, implementing an efficient capital structure, and improving profit margins in its enterprise solutions segment.

Taconic Capital is CA’s largest activist hedge fund stakeholder. The company has a portfolio value of $3.65 billion in the third quarter 2011. The firm mainly invests in Healthcare, Technology, and Industrial Goods sector. Now Taconic Capital has a significantly larger position in the company than any other hedge funds we track. Cliff Asness’s Aqr Capital Management decreased its position by 5% and remained 640 thousand shares at the end of September. Jim Simons’ Renaissance Technologies initiated a new position of 556 thousand shares of CA during the third quarter.

CA, Inc. (CA) is “an independent enterprise information technology (IT) management software and solutions company. CA is engaged in the design, development, marketing, licensing and support of IT management software products that operate on a wide range of hardware platforms and operating systems.” according to Google Finance.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!